标题
Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 9, Pages e73635
出版商
Public Library of Science (PLoS)
发表日期
2013-09-05
DOI
10.1371/journal.pone.0073635
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- LRIG2 Mutations Cause Urofacial Syndrome
- (2013) Helen M. Stuart et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor
- (2012) Anne E. Powell et al. CELL
- Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling
- (2012) Vivian W. Y. Wong et al. NATURE CELL BIOLOGY
- Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ER -Positive Breast Cancer
- (2011) S. R. Krig et al. MOLECULAR CANCER RESEARCH
- LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix
- (2010) Håkan Hedman et al. ACTA ONCOLOGICA
- Identifying common prognostic factors in genomic cancer studies: A novel index for censored outcomes
- (2010) Sigrid Rouam et al. BMC BIOINFORMATICS
- Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian Epidermis
- (2009) Kim B. Jensen et al. Cell Stem Cell
- Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival
- (2009) Camilla Holmlund et al. NEUROPATHOLOGY
- Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice
- (2008) Yuexing Zhang et al. BMC CELL BIOLOGY
- Reduced body weight is a common effect of gene knockout in mice
- (2008) Danielle R Reed et al. BMC GENETICS
- Gliomas With 1p/19q Codeletion:a.k.a. Oligodendroglioma
- (2008) Gregory Cairncross et al. CANCER JOURNAL
- Lrig3 regulates neural crest formation in Xenopus by modulating Fgf and Wnt signaling pathways
- (2008) H. Zhao et al. DEVELOPMENT
- Cross-repressive interactions between Lrig3 and netrin 1 shape the architecture of the inner ear
- (2008) V. E. Abraira et al. DEVELOPMENT
- Lrig1 Is an Endogenous Inhibitor of Ret Receptor Tyrosine Kinase Activation, Downstream Signaling, and Biological Responses to GDNF
- (2008) F. Ledda et al. JOURNAL OF NEUROSCIENCE
- LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking
- (2007) A.K. LINDSTRÖM et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Redistribution of LRIG Proteins in Psoriasis
- (2007) Terese Karlsson et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started